Use of amantadine for treatment of hepatitis c

Details Use of amantadine for treatment of hepatitis c Use of amantadine for treatment of hepatitis c

A - Human Necessities

61

K

A61K 31/13 (2006.01)

Patent

CA 2285292

Methods for treating patients with viral infection with pharmaceutical agents are disclosed. In one embodiment, the virus is Hepatitis C and the pharmaceutical agent is amantadine. The methods of the present invention can be used in patients that have not responded to or cannot tolerate interferon treatment, as well as patients under the age of eighteen.

L'invention porte sur des procédés visant à traiter, au moyen d'agents pharmaceutiques, des patients atteints par des infections virales. Selon une réalisation, le virus est celui de l'hépatite C et l'agent pharmaceutique est l'amantadine. Les procédés de cette invention peut être utilisés sur des patients qui n'ont pas réagi ou ne peuvent tolérer le traitement à l'interféron, et sur des patients ayant en dessous de 18 ans.

Affiliated with

Also associated with

Rating

Use of amantadine for treatment of hepatitis c does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of amantadine for treatment of hepatitis c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of amantadine for treatment of hepatitis c will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1674897